Media Centre - Neurochase

NEUROCHASE ANNOUNCES ACQUISITION OF STRATEGIC RENISHAW NEURO SOLUTIONS’ ASSETS

DuncanarioNCH November 20, 2025 No Comments

CREATING A PREMIER GLOBAL PLATFORM FOR TARGETED CNS DRUG DELIVERY – Sale agreement for Renishaw Neuro Solutions’ Neuroinfuse™ drug delivery system a key milestone as Neurochase prepares to use this pioneering CNS…

Neurochase to exhibit and present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting next month

Peter Carroll April 23, 2025 No Comments

We can confirm today (Wednesday, April 23, 2025) that Neurochase will be a first-time exhibitor at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting next month.…

Neurochase Appoints New Chief Marketing Officer

DuncanarioNCH March 7, 2025 No Comments

Pharmaceutical and medical device industry veteran Jacqueline Keller joins Neurochase as the company prepares to bring its pioneering CED drug delivery device for CNS indications to market – Neurochase has…

VIVOLTA partners with Neurochase

DuncanarioNCH November 13, 2024 No Comments

VIVOLTA partners with Neurochase to manufacture electrospun micro-catheters delivering advanced CNS therapies to the brain Waalre, The Netherlands, 13 November 2024 – VIVOLTA, the medical electrospinning solutions provider, has signed a long-term partnership…

News & Articles

NEUROCHASE ANNOUNCES ACQUISITION OF STRATEGIC RENISHAW NEURO SOLUTIONS’ ASSETS

Neurochase to exhibit and present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting next month

Neurochase Appoints New Chief Marketing Officer

VIVOLTA partners with Neurochase